PER 0.00% 13.5¢ percheron therapeutics limited

Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD, page-35

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,446 Posts.
    lightbulb Created with Sketch. 532
    they need to finish phase 2b which is 2 years away.
    They most likely need that to get fda approval
    so 2 years away. But fda is liking what they seeing but nothing 100% its still a long long wait still.
    The share price will die off in a year n pick up towards 2b being finish.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.